BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-1.34%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$388M
AUM Growth
+$388M
(+97%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
53.44%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
2
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$158M |
| 2 |
Dynavax Technologies
DVAX
|
$30.3M |
| 3 |
Solid Biosciences
SLDB
|
$19.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 70.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
| $158M | 40.64% | +7,281,307 | New | +$158M |
|
|
DRNA
2
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $105M | 27.1% | 7,330,237 | – | – |
|
|
3
Solid Biosciences
SLDB
$427M
| $40M | 10.31% | 3,871,164 +1,881,720 | +95% | +$19.5M |
|
4
Replimune Group
REPL
$422M
| $39.5M | 10.16% | 2,838,968 | – | – |
|
|
5
Dynavax Technologies
DVAX
$1.19B
| $30.3M | 7.79% | +8,452,235 | New | +$30.3M |
|
|
MRNS
6
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7.77M | 2% | 5,042,735 | – | – |
|
|
APTX
7
DELISTED
Aptinyx Inc. Common Stock
APTX
| $7.77M | 2% | 2,225,092 | – | – |
|